Levels of bone markers in a population of infants exposedin uteroand during breastfeeding to tenofovir within an Option B+ programme in Malawi | Zendy

Marco Floridia | Zendy; Giuseppe Liotta | Zendy; Mauro Andreotti | Zendy; Clementina Maria Galluzzo | Zendy; Roberta Amici | Zendy; Haswell Jere | Zendy; JeanBaptiste Sagno | Zendy; Maria Cristina Marazzi | Zendy; E Buonomo | Zendy; P Scarcella | Zendy; S Mancinelli | Zendy; Stefano Vella | Zendy; Marina Giuliano | Zendy; Leonardo Palombi | Zendy

Open Access

Levels of bone markers in a population of infants exposedin uteroand during breastfeeding to tenofovir within an Option B+ programme in Malawi

Author(s) -

Marco Floridia,

Giuseppe Liotta,

Mauro Andreotti,

Clementina Maria Galluzzo,

Roberta Amici,

Haswell Jere,

JeanBaptiste Sagno,

Maria Cristina Marazzi,

E Buonomo,

P Scarcella,

S Mancinelli,

Stefano Vella,

Marina Giuliano,

Leonardo Palombi

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkw268

Subject(s) - efavirenz , medicine , breastfeeding , bone remodeling , n terminal telopeptide , tenofovir , breast feeding , bone resorption , physiology , population , endocrinology , obstetrics , pediatrics , alkaline phosphatase , biology , human immunodeficiency virus (hiv) , viral load , immunology , osteocalcin , biochemistry , environmental health , antiretroviral therapy , enzyme

No data are available on bone metabolism in infants exposed to tenofovir during breastfeeding. We investigated bone metabolism markers in the first year of life in infants from mothers who received tenofovir, lamivudine and efavirenz during pregnancy and 12 months of breastfeeding in a national Option B+ programme in Malawi.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research